Literature DB >> 8764144

SRF and TEF-1 control of chicken skeletal alpha-actin gene during slow-muscle hypertrophy.

J A Carson1, R J Schwartz, F W Booth.   

Abstract

The purpose of this study was to delineate the alpha-actin regulatory elements and transcription factors that are responsible for conferring stretch-overload responsiveness during hypertrophy of the anterior latissimus dorsi (ALD) muscle of young chickens by weighting one wing. Minimal promoter constructs were evaluated by direct injection into the ALD, which demonstrated that both serum response element 1 (SRE1) and the transcriptional enhancer factor 1 (TEF-1) elements were sufficient for increased expression during stretch overload. A mutated SRE1 prevented expression in both basal and stretched ALD muscles, whereas a mutated TEF-1 element reduced actin promoter function in both control and stretched muscles. The serum response factor (SRF)-SRE1 binding complex demonstrated faster migration in mobility shift assays from day 3-and day 6-stretched ALD nuclear extracts relative to their control. TEF-1 binding was qualitatively increased in stretched extracts at day 3 but not day 6 of stretch overload. Skeletal alpha-actin mRNA accumulated from day 3 to day 6 of stretch overload. These data demonstrate that SRE1 is necessary and sufficient for stretch-overload responsiveness from the skeletal alpha-actin promoter and that the SRF-SRE1 binding complex migrates faster in stretched nuclear extracts of hypertrophied relative to control extracts from intact ALD muscles of chickens.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8764144     DOI: 10.1152/ajpcell.1996.270.6.C1624

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  22 in total

1.  Activation of the skeletal alpha-actin promoter during muscle regeneration.

Authors:  D R Marsh; J A Carson; L N Stewart; F W Booth
Journal:  J Muscle Res Cell Motil       Date:  1998-11       Impact factor: 2.698

Review 2.  Titin-based mechanosensing and signaling: role in diaphragm atrophy during unloading?

Authors:  Coen A C Ottenheijm; Hieronymus W H van Hees; Leo M A Heunks; Henk Granzier
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-11-12       Impact factor: 5.464

3.  Insights into transcription enhancer factor 1 (TEF-1) activity from the solution structure of the TEA domain.

Authors:  Asokan Anbanandam; Diana C Albarado; Catherine T Nguyen; Georg Halder; Xiaolian Gao; Sudha Veeraraghavan
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-03       Impact factor: 11.205

Review 4.  Cellular and molecular events controlling skeletal muscle mass in response to altered use.

Authors:  François B Favier; Henri Benoit; Damien Freyssenet
Journal:  Pflugers Arch       Date:  2008-01-12       Impact factor: 3.657

Review 5.  Excitation-transcription coupling in skeletal muscle: the molecular pathways of exercise.

Authors:  Kristian Gundersen
Journal:  Biol Rev Camb Philos Soc       Date:  2010-10-06

Review 6.  The STARS signaling pathway: a key regulator of skeletal muscle function.

Authors:  Séverine Lamon; Marita A Wallace; Aaron P Russell
Journal:  Pflugers Arch       Date:  2014-02-21       Impact factor: 3.657

7.  RhoA induction by functional overload and nandrolone decanoate administration in rat skeletal muscle.

Authors:  Joseph M McClung; Won J Lee; Raymond W Thompson; Larry L Lowe; James A Carson
Journal:  Pflugers Arch       Date:  2003-10-11       Impact factor: 3.657

8.  Rapid muscle atrophy response to unloading: pretranslational processes involving MHC and actin.

Authors:  Julia M Giger; Paul W Bodell; Ming Zeng; Kenneth M Baldwin; Fadia Haddad
Journal:  J Appl Physiol (1985)       Date:  2009-07-23

9.  VITO-1 is an essential cofactor of TEF1-dependent muscle-specific gene regulation.

Authors:  Stefan Günther; Michal Mielcarek; Marcus Krüger; Thomas Braun
Journal:  Nucleic Acids Res       Date:  2004-02-03       Impact factor: 16.971

10.  A novel cell-based system for evaluating skeletal muscle cell hypertrophy-inducing agents.

Authors:  Doreen Cross-Doersen; Robert J Isfort
Journal:  In Vitro Cell Dev Biol Anim       Date:  2003 Nov-Dec       Impact factor: 2.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.